News

The companies have extended their agreement to pursue the development of a further blood factor product, TheraPEG Factor VIIa and go ahead with the feasibility study to assess

The decision will help Ranbaxy Laboratories and Dr Reddy’s Laboratories gain larger sales of the medicine in the US, the Economic Times of India reported. Teva Americas president

MabThera, also known as Rituxan, was declared safe to use, following a contamination scare at Roche’s facility in Vacaville, California, US. MabThera is used to treat non-Hodgkin’s lymphoma

The study demonstrated that PD421 significantly reduced the incidence of nausea and vomiting compared to placebo in adult surgical patients. Acacia CEO Julian Gilbert said anaesthetists seek a

The police officers discovered that acetone and sulfuric acid are being transported through Peru’s central Amazonian region, and during the operation, Peruvian authorities seized 680kg of cocaine paste,

The new investment by Teralys Capital, together with investments by Eli Lilly and Company and other partners amounts to $150m, and enables a new investment model in Québec.

Gelatine is required for the production of hard and soft gel capsules in the country. Ossein is a semi-finished product of gelatine. The European Commission has announced new

The grant will support the development of a T cell-based immunotherapy that re-directs patient’s immune response against glioma stem cells for the treatment of cancer. In the research,

The orphan drug status offers seven years marketing exclusivity from the time of approval and provides benefits such as tax incentives, reduced user fees and assistance for the